Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Expenditures for care of rural Chinese AIDS patients in their first year of antiretroviral therapy (US dollars) (N = 276)

From: Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs

Expenditure item Calculation formula Total expenditures (%) Average per capita expenditures
ARV medications (Daily consultative price of ARV regimen) × (days taken actually) $618,832 (85.1) $2,242
Inpatient and outpatient medications for treating ADEs (Daily wholesale price of medication for OIs or ADEs) × (prescribed dosage) $18,151 (2.5) $66
Inpatient and outpatient medications for treating OIs   $12,383 (1.8) $45
ART laboratory monitoring   $55,281 (7.6) $200
Inpatient and outpatient laboratory tests for diagnosing ADEs Wholesale price for reagent, equipment depreciation, service charge, charges for use of space, water, electricity $2,588 (0.4) $9
Inpatient and outpatient laboratory tests for diagnosing OIs   $2,909 (0.4) $11
Inpatient and outpatient medical service charges for treating ADEs   $8,964 (1.1) $32
Inpatient and outpatient medical service charges for treating OIs Local reference price for items of medical service $7,739 (1.0) $28
Total   $726,847 (100.0) $2,633
  1. ARV, antiretroviral; ART, antiretroviral therapy; ADEs, adverse drug events; OIs, opportunistic infections.